Differences in dietary choices in patients who developed postprandial hyperinsulinemic hypoglycemia (dumping syndrome) after Roux-en-Y gastric bypass compared to healthy controls
The most commonly reported side effects of retatrutide in clinical trials are gastrointestinal, including nausea, vomiting, diarrhoea, constipation, and decreased appetite, consistent with other GLP-1-based therapies
Every channel I tested connected me to a real person who responded politely and helpfully within 24 hours
A study has shown that mature cell only express low levels of PC1/3 (Kilimnik et al., 2010), and GLP-1R agonists increase cell PC1/3 expression through a cell GLP-1R dependent manner (Garibay et al., 2018
In Phase II clinical trials in adults with overweight or obesity, once-daily orforglipron led to 9-15% mean weight loss at 36 weeks, with a GI tolerability profile typical of the class
CrossRef A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management Clara Garca-Carro, Ander Vergara, Sheila Bermejo, Mara A
